This study will evaluate patients on both buprenorphine and full agonist opioids (FAO) to
assess for withdrawal symptoms. Patients will be evaluated by clinicians and using validated
tools to assess for pain and withdrawal. At the same time, patients will use a CPM Rx
application on their phone to track medication use.